| Company |
Product |
Recruitment/trial status |
Last updated |
| 480 Biomedical*& Arsenal Vascular |
Arsnal Vascular Bioresorbable Scaffold System |
Currently recruiting |
2011-Nov |
| Azaya Therapeutics |
ATI-1123 (active drug = docetaxel) |
Phase 1- completed |
2012-Sep |
| BIND Biosciences |
BIND-014 |
Study demonstrated safety and tolerability, and showed evidence of anti-tumor activity with six of 17 patients with advanced or metastatic solid tumor cancers. |
2012-Apr |
| Celator Pharmaceuticals |
CPX-1 (IrinotecanHCl:Floxuridine) Liposome Injection |
Phase 2- Completed |
2012-May |
| Celator Pharmaceuticals |
CPX-351 |
Phase 3- currently recruiting |
2012-Nov |
| CytImmune Sciences, Inc |
Aurimune (CYT-6091) |
Phase 1- completed |
2012-Dec |
| CytImmune Sciences, Inc |
AURITOLTM (CYT-21001) |
Preclinical development |
2006-Mar |
| Hologic |
Hologic digital mammography units |
This study is ongoing, but not recruiting participants. |
2012-Mar |
| Hologic |
Hologic's new 3D Hip(TM) software |
This study is ongoing, but not recruiting participants. |
2011-Jul |
| Hologic |
TIGRIS System |
Device approval |
2012-Oct |
| Luna NanoWorks |
HYDROCHALARONETM |
Preclinical- not currently recruiting |
2008-Apr |
| MicroCHIPS, Inc. |
hPTH 1-34 implantable delivery system (Implantable, Wireless MicroChip Drug Delivery Device) |
Pharmacokinetics of long-term parathyroid hormone (hPTH 1-34) delivery in women with osteoporosis; Successful human clinical trial |
2012-Feb |
| Nanospectra Biosciences |
AuroLase® Therapy |
Pilot study- currently recruiting patients. |
2012-Oct |
| Nanospectra Biosciences |
AuroLase® Therapy |
Pilot study- currently recruiting patients. |
2013-Jan |
| Nanosphere |
Gram-positive blood culture test |
De Novo classification granted by FDA Jun-12 |
2012-Jun |
| Nanosphere |
Multi-Analyte, Genetic, and Thrombogenic Markers of Atherosclerosis |
Recruiting Jun-10; completion date Dec-12 |
2011-Oct |
| Nanosphere |
Serial Troponin Testing |
Officially unknown; changed from active/not recruiting Jan-10 |
2010-Jan |
| PDS Biotechnology |
VersamuneTM |
Phase 1- completed |
2010-Mar |
| Pervasis Therapeutics |
Vascugel |
Completed phase I and II as of Jun-2010; awaiting phase III; no study results posted |
2011-Oct |
| Pulmatrix |
CALMs |
Completed Apr-2011; no study results posted |
2011-Apr |
| Pulmatrix |
PUR003 |
Phase I drug trial completed nov-2011; no study results posted |
2011-Nov |
| Pulmatrix |
PUR003 |
Phase I completed Apr-2010; no study results posted |
2010-Apr |
| Pulmatrix |
PUR118 |
Currently recruiting participants 09-2012 |
2012-Sep |
| Pulmatrix |
PUR118 |
Currently recruiting participants 09-2012 |
2012-Sep |
| Pulmatrix |
PUR118 |
Phase I completed Sep-2012; no study results posted |
2012-Sep |
| Selecta Biosciences |
SEL-068 Vaccine |
Currently recruiting participants for Phase I Biological 11-2011 |
2011-Nov |
| SemprusBioSciences |
PRISM - 1 |
This study is not yet open for participant recruitment. |
2012-Apr |
| T2 Biosystems |
DIRECT T2 Candida Assay |
This study is currently recruiting participants. |
2012-Mar |
| TARIS BioMedical |
LiRIS |
This study has been completed. |
2011-Nov |
| TARIS BioMedical |
LiRIS |
This study is ongoing, but not recruiting participants. |
2012-Jul |
| TARIS BioMedical |
Taris Placebo System |
This study has been completed. |
2010-Jan |
